XML 48 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Fair value of stock-based awards granted to employees, directors, and, in 2018, non-employees, subsequent to the adoption of ASU 2018-07  
Schedule of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted

 

 

 

 

 

 

 

average

 

average

 

Aggregate

 

 

Number of

 

exercise

 

contractual

 

intrinsic

 

    

shares

    

price

    

term

    

value

 

 

 

 

 

 

 

(in years)

 

(in thousands)

Outstanding as of December 31, 2018

 

14,784,770

 

$

8.93

 

8.89

 

$

126,367

Granted

 

3,059,004

 

 

12.67

 

  

 

 

  

Exercised

 

(1,449,309)

 

 

1.68

 

  

 

 

  

Forfeited

 

(1,290,558)

 

 

8.58

 

  

 

 

  

Outstanding as of December 31, 2019

 

15,103,907

 

$

10.41

 

8.22

 

$

36,006

Vested and expected to vest as of December 31, 2019

 

15,103,907

 

$

10.41

 

8.22

 

$

36,006

Options exercisable as of December 31, 2019

 

5,182,808

 

$

6.33

 

7.49

 

$

21,743

 

Schedule of restricted common stock award activity

 

 

 

 

 

 

 

 

 

 

Weighted average

 

 

 

 

grant‑date

 

    

Shares

    

fair value

Unvested restricted common stock as of December 31, 2018

 

1,559,401

 

$

0.502

Issued

 

 —

 

 

 —

Vested

 

(1,258,837)

 

 

0.519

Forfeited

 

(201,250)

 

 

0.387

Unvested restricted common stock as of December 31, 2019

 

99,314

 

$

0.526

 

Schedule of restricted stock unit activity

 

 

 

 

 

 

 

 

 

 

Weighted average

 

 

 

 

grant‑date

 

    

Shares

    

fair value

Unvested restricted common stock as of December 31, 2018

 

 —

 

$

 —

Issued

 

277,200

 

 

10.660

Vested

 

 —

 

 

 —

Forfeited

 

 —

 

 

 —

Unvested restricted common stock as of December 31, 2019

 

277,200

 

$

10.660

 

Schedule of allocation of share based compensation

The Company recorded stock-based compensation expense in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 

 

2019

    

2018

    

2017

Research and development expenses

$

9,011

 

$

3,787

 

$

1,756

General and administrative expenses

 

32,260

 

 

23,741

 

 

16,147

 

$

41,271

 

$

27,528

 

$

17,903

 

Employees, directors and non-employees  
Fair value of stock-based awards granted to employees, directors, and, in 2018, non-employees, subsequent to the adoption of ASU 2018-07  
Schedule of assumptions used to determine the fair value of stock awards granted

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 

 

    

2019

 

2018

 

2017

Risk-free interest rate

 

2.07

%

 

2.71

%

 

2.05

%

Expected volatility

 

76.9

%

 

74.0

%

 

75.6

%

Expected dividend yield

 

 —

 

 

 —

 

 

 —

 

Expected term (in years)

 

6.06

 

 

6.21

 

 

6.39

 

 

Market-Based Stock Options  
Fair value of stock-based awards granted to employees, directors, and, in 2018, non-employees, subsequent to the adoption of ASU 2018-07  
Schedule of assumptions used to determine the fair value of stock awards granted

 

 

 

 

 

 

Year ended December 31, 

 

 

    

2018

    

Risk-free interest rate

 

3.15

%

Expected volatility

 

69.0

%

Expected dividend yield

 

 —

 

Derived service period (in years)

 

2.30

 

 

ASU 2018-07  
Fair value of stock-based awards granted to employees, directors, and, in 2018, non-employees, subsequent to the adoption of ASU 2018-07  
Schedule of assumptions used to determine the fair value of stock awards granted

 

 

 

 

 

Year ended December 31, 

 

    

2017

Risk-free interest rate

 

2.02% - 2.31%

Expected volatility

 

74% - 85%

Expected dividend yield

 

 —

Expected term (in years)

 

6 - 10

Fair value of common stock

 

$0.19 - $6.28